Coronary Artery Disease in Women: Lessons Learned from Single-Center SPECT Registry and Future Directions for INOCA

Barbara Vitola1,2, Karlis Trusinskis1,2, Iveta Mintale1,3

  • 1Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.

Medicina (Kaunas, Lithuania)
|September 23, 2022
PubMed

Insights

Cardiac SPECT accurately detects myocardial perfusion defects in women. Further invasive testing is crucial for diagnosing ischemia with nonobstructive coronary artery disease (INOCA) and tailoring treatment.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Cardiac single-photon emission tomography (SPECT) is effective for detecting coronary artery disease (CAD) in women.
  • A significant number of women with perfusion defects on SPECT lack obstructive CAD, a condition known as ischemia with nonobstructive coronary artery disease (INOCA).
  • Current diagnostic and therapeutic strategies for INOCA are insufficient due to underdiagnosis of its specific endotypes.

Purpose of the Study:

  • To evaluate the role of cardiac SPECT in identifying women with potential INOCA.
  • To assess the correlation between SPECT findings, clinical characteristics, and cardiovascular risk factors in women.
  • To identify candidates for invasive microvascular physiology measurements for INOCA diagnosis.

Main Methods:

  • Analysis of 726 women with suspected CAD who underwent cardiac SPECT between 2018 and 2021.
  • Coronary angiography was performed to assess for obstructive CAD.
  • Patients meeting INOCA criteria were selected for further invasive diagnostic testing.

Main Results:

  • True myocardial perfusion defects were identified in 17.2% of women.
  • 56.0% of women with perfusion defects showed no obstructive epicardial coronary artery disease (CAD).
  • Perfusion defects correlated with cardiovascular risk factors like obesity and hypertension; typical angina was associated with INOCA.

Conclusions:

  • Cardiac SPECT plays a vital role in identifying women with potential INOCA.
  • There is a significant need for invasive physiological measurements to diagnose INOCA.
  • Combining SPECT with invasive testing could revolutionize INOCA patient management and improve outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
25